The Novallele™ copy number assays simply and accurately determine SMN1 and SMN2gene copy number MELVILLE, N.Y. Everyone wants to run and enjoy an active, physically enabled lifestyle. Spinal muscular atrophy (SMA) slowly takes that away as nerve cells in the spinal cord break down and die. Most cases of SMA are related to the deletion of a specific […]
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types Exclusive IP licensed from the University of Cambridge Geographically diversified, top-tier investor team includes key industry leaders to support early company development Cambridge, UK: Elpis BioMed, a University of Cambridge spin-out, applying its disruptive and proprietary “direct cell […]
As part of the expansion of their Next Generation Sequencing (NGS) products and services, LGC’s Genomics division has signed a distribution with Diagenode to supply a range of state-of-the-art sonication systems for DNA fragmentation. The agreement covers EMEA, South America and Canada for clinical and agricultural biotechnology market sectors and the United States for the agricultural biotechnology sector. Brian […]
Oxford, England & San Francisco, California. Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast™ technology […]
Oxford Nanopore’s goal is to enable the analysis of any living thing, by anyone, anywhere. To get closer to this, we want to abolish the cold chain so that our reagents can be transported easily to any researcher and be used in any environment. With this in mind, we are now starting an early release of […]
SALT LAKE CITY — Today at the Association for Molecular Pathology (AMP) 2017 Annual Meeting, Edico Genome announced an affiliation with Children’s Hospital Los Angeles (CHLA). The hospital will utilize Edico Genome’s DRAGENTM Bio-IT platform to deliver enhanced patient care and accelerate research initiatives to expand test offerings for children with genetic disorders and cancer. CHLA has validated […]
First bioinformatics solution integrating new AMP/ASCO/CAP standards for NGS cancer testing to confidently and quickly report clinical relevance of somatic mutations Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and […]
Systems, reagents and software to cover broad range of clinical applications SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the introduction of its NextSeq™ 550Dx instrument, the company’s second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system. The company also announced that the intended use for the MiSeq™Dx instrument has been updated to include the […]
Wädenswil & Villigen, Switzerland – Creoptix and leadXpro AG announce the selection of the Creoptix WAVE technology by leadXpro to strengthen its capabilities for drug discovery aimed at identifying and optimizing drug candidates directed against challenging membrane protein drug targets. Creoptix provides leadXpro with the Creoptix WAVEdelta system, its latest technology for real-time label-free molecular interaction […]
Solution enables clinical labs that perform cancer NGS testing to quickly convert genomic insights to targeted therapies SALT LAKE CITY—-This week, at the Association for Molecular Pathology (AMP) Annual Meeting, Fabric Genomicswill announce its expanded somatic cancer solution which provides seamless genomic analysis and clinical reporting to clinical labs. The offering enables therapy matching for cancer […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
